Several studies have revealed that brain insulin resistance, which means dysregulated brain insulin signaling, is one of the factors of cognitive disorders and Alzheimer’s disease (AD) and is also considered a risk factor for sporadic AD development (86, 87). Here, INS is linked to cognitive disorder.